Panacea Life Sciences Holdings, Inc. Net Income (Loss) Available to Common Stockholders, Basic
Panacea Life Sciences Holdings, Inc. (PLSH) reported Net Income (Loss) Available to Common Stockholders, Basic of -$6.93 million for the 3-month period ending 2021-03-31, per its 10-Q/A filed 2021-05-27.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2021-05-27
- Panacea Life Sciences Holdings, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2021-03-31 was -$6.93M.
- Panacea Life Sciences Holdings, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2020-12-31 was -$3.38M.
- Panacea Life Sciences Holdings, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2020-09-30 was -$1.89M.
- Panacea Life Sciences Holdings, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2020-06-30 was -$1.53M.
- Panacea Life Sciences Holdings, Inc. net income (loss) available to common stockholders, basic for fiscal 2020 was -$9.46M.
- Panacea Life Sciences Holdings, Inc. net income (loss) available to common stockholders, basic for fiscal 2019 was -$10.39M.
- Panacea Life Sciences Holdings, Inc. net income (loss) available to common stockholders, basic for fiscal 2018 was -$4.34M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2021-03-31 | -$6.93M 10-Q/A · filed 2021-05-27 | -$3.08M 10-Q · filed 2021-05-24 | -$10.31M derived: sum of 2 quarters · filed 2021-05-27 | -$12.20M derived: sum of 3 quarters · filed 2021-05-27 | -$13.73M derived: sum of 4 quarters · filed 2021-05-27 | ||
| 2020-12-31 | -$3.38M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23 | -$5.27M derived: sum of 2 quarters · filed 2021-04-23 | -$6.79M derived: sum of 3 quarters · filed 2021-04-23 | -$9.46M 10-K/A · filed 2021-04-23 | |||
| 2020-09-30 | -$1.89M 10-Q · filed 2020-11-18 | -$3.42M derived: sum of 2 quarters · filed 2020-11-18 | -$6.08M 10-Q · filed 2020-11-18 | -$11.38M derived: sum of 4 quarters · filed 2021-05-27 | |||
| 2020-06-30 | -$1.53M 10-Q · filed 2020-08-19 | -$4.20M 10-Q · filed 2020-08-19 | -$9.50M derived: sum of 3 quarters · filed 2021-05-27 | -$11.35M derived: sum of 4 quarters · filed 2021-05-27 | |||
| 2020-03-31 | -$2.67M 10-Q/A · filed 2021-05-27 | -$2.79M 10-Q · filed 2020-06-29 | -$7.97M derived: sum of 2 quarters · filed 2021-05-27 | -$9.82M derived: sum of 3 quarters · filed 2021-05-27 | -$11.67M derived: sum of 4 quarters · filed 2021-05-27 | ||
| 2019-12-31 | -$5.30M derived: 10-K/A 12 month − 10-K/A 9 month · filed 2021-04-23 | -$7.15M derived: sum of 2 quarters · filed 2021-04-23 | -$9.00M derived: sum of 3 quarters · filed 2021-04-23 | -$10.39M 10-K/A · filed 2021-04-23 | -$10.59M 10-K · filed 2020-05-22 | ||
| 2019-09-30 | -$1.85M 10-K/A · filed 2021-04-23 | -$1.93M 10-Q · filed 2019-11-14 | -$3.70M derived: sum of 2 quarters · filed 2021-04-23 | -$5.09M 10-K/A · filed 2021-04-23 | -$5.17M 10-Q · filed 2019-11-14 | -$7.09M derived: sum of 4 quarters · filed 2021-04-23 | |
| 2019-06-30 | -$1.85M 10-Q · filed 2020-11-18 | -$955.23K 10-Q · filed 2019-08-14 | -$3.23M 10-Q · filed 2020-08-19 | -$5.24M derived: sum of 3 quarters · filed 2020-11-18 | -$6.83M derived: sum of 4 quarters · filed 2020-11-18 | ||
| 2019-03-31 | -$2.28M 10-Q · filed 2020-06-29 | -$3.39M derived: sum of 2 quarters · filed 2020-06-29 | -$4.98M derived: sum of 3 quarters · filed 2020-06-29 | -$5.54M derived: sum of 4 quarters · filed 2020-06-29 | |||
| 2018-12-31 | -$1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-22 | -$2.70M derived: sum of 2 quarters · filed 2020-05-22 | -$3.26M derived: sum of 3 quarters · filed 2020-05-22 | -$4.34M 10-K · filed 2020-05-22 | |||
| 2018-09-30 | -$1.60M 10-Q · filed 2019-11-14 | -$2.15M derived: sum of 2 quarters · filed 2019-11-14 | -$3.23M 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | -$559.71K 10-Q · filed 2019-08-14 | -$1.63M 10-Q · filed 2019-08-14 | |||||
| 2018-03-31 | -$1.07M 10-Q · filed 2019-05-20 |